Phase I Basket Study of Taselisib, an Isoform-Selective...

  • Main
  • 2020 / 11
  • Phase I Basket Study of Taselisib, an Isoform-Selective...
Clinical Cancer Research 2020 / 11

Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA -Mutant Cancers

Jhaveri, Komal, Chang, Matthew T, Juric, Dejan, Saura, Cristina, Gambardella, Valentina, Melnyk, Anton, Patel, Manish R., Ribrag, Vincent, Ma, Cynthia X., Aljumaily, Raid, Bedard, Philippe L., Sachdev
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-2657
Date:
November, 2020
File:
PDF, 1.69 MB
2020
Conversion to is in progress
Conversion to is failed